Titan, with a low stock price, large potential commercial market and enough cash on hand, has all the ingredients for a beautiful run up into the advisory panel. Messier is long Titan shares.
Here are Monday's top research calls, including upgrades for American Eagle, Mattel and Tesaro, and new coverage of Netflix.
Titan Pharmaceuticals (TTNP) stock is climbing after the FDA's Psychopharmacologic Drugs Advisory Committee voted in favor of approving the company's treatment for opioid addiction.
These under-$10 biotech stocks are within range of triggering major breakout trades.
Titan and its partner will resubmit Probuphine for FDA approval later this year.